Rapid Micro Biosystems Q1 2025 10-Q Filed
Ticker: RPID · Form: 10-Q · Filed: May 9, 2025 · CIK: 1380106
| Field | Detail |
|---|---|
| Company | Rapid Micro Biosystems, Inc. (RPID) |
| Form Type | 10-Q |
| Filed Date | May 9, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, reporting
TL;DR
**RMB filed its Q1 2025 10-Q. Financials are in. Check it out.**
AI Summary
Rapid Micro Biosystems, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 2025. Key financial figures and business segments are presented, reflecting the company's ongoing activities in the laboratory analytical instruments sector.
Why It Matters
This filing provides investors and analysts with the latest financial health and operational status of Rapid Micro Biosystems, crucial for understanding its market position and future prospects.
Risk Assessment
Risk Level: medium — As a 10-Q filing, it contains detailed financial information that could reveal performance trends, but it doesn't inherently signal a new, immediate risk without further analysis of the content.
Key Numbers
- 20250331 — Period End Date (Indicates the end of the financial reporting quarter.)
- 20250509 — Filing Date (Shows when the report was officially submitted to the SEC.)
Key Players & Entities
- RAPID MICRO BIOSYSTEMS, INC. (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250509 (date) — Filing date
- 20250101 (date) — Start of the reporting period
FAQ
What is the total revenue for the quarter ending March 31, 2025?
The provided text does not contain specific revenue figures for the quarter ending March 31, 2025.
What were the net earnings or losses for the period?
The filing text does not specify the net earnings or losses for the period ending March 31, 2025.
Are there any significant changes in the company's debt structure reported?
The filing mentions 'LeaseLiabilityCurrent' and 'LeaseLiabilityNoncurrent', indicating lease-related liabilities, but does not detail overall debt structure changes.
What is the company's cash and cash equivalents balance as of March 31, 2025?
Specific figures for cash and cash equivalents are not present in the provided excerpt.
Does the filing mention any new product launches or significant business developments?
The provided text is a header and does not contain details on new product launches or business developments.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 9, 2025 regarding RAPID MICRO BIOSYSTEMS, INC. (RPID).